Teva Pharmaceutical Industries
Teva Pharmaceutical Finance is a special purpose financing vehicle created to issue debt securities for Teva Pharmaceutical Industries Ltd. The entity's sole function is to raise capital in the international bond markets to finance the corporate and operational activities of its parent group. Teva Pharmaceutical Industries operates as a global pharmaceutical company specializing in generic medicines, specialty pharmaceuticals, and active pharmaceutical ingredients. The primary revenue drivers for the underlying business are global prescription drug sales across therapeutic areas such as central nervous system disorders and oncology. The company represents a core financing structure for one of the largest generic pharmaceutical manufacturers globally. Managed alongside its parent entity, it is headquartered in Tel Aviv, Israel, with its issued debt instruments listed on international financial exchanges.
37 of the funds FundTelligence covers report a position in Teva Pharmaceutical Industries.
- Legal name
- Teva Pharmaceutical Industries Ltd
- Sector
- Health Care
- Country
- Israel
- Funds holding it
- 37
Funds holding Teva Pharmaceutical Industries
- Polar Capital Healthcare Opportunities Fund — Polar Capital · 6.6 % (largest positions only, October 2026)
- FAST Global Fund — Fidelity · 5.1 % (largest positions only, October 2026)
- Polar Capital Global Healthcare Select Fund — Polar Capital · 5.0 % (largest positions only, October 2026)
- Schroder ISF Hlthcr Innovt — Schroders · 3.0 % (largest positions only, September 2026)
- SEB Läkemedelsfond — SEB · 2.66 % (full portfolio disclosed, June 2026)
- Schroder ISF Healthcare Innovation — Schroders · 2.43 % (full portfolio disclosed, June 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 2.32 % (full portfolio disclosed, October 2026)
- Nordea European Cross Credit — Nordea Funds · 1.71 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 37 funds holding it.